These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26586445)

  • 1. Do cost savings from reductions in nosocomial infections justify additional costs of single-bed rooms in intensive care units? A simulation case study.
    Sadatsafavi H; Niknejad B; Zadeh R; Sadatsafavi M
    J Crit Care; 2016 Feb; 31(1):194-200. PubMed ID: 26586445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probabilistic Return-on-Investment Analysis of Single-Family Versus Open-Bay Rooms in Neonatal Intensive Care Units-Synthesis and Evaluation of Early Evidence on Nosocomial Infections, Length of Stay, and Direct Cost of Care.
    Sadatsafavi H; Niknejad B; Shepley M; Sadatsafavi M
    J Intensive Care Med; 2019 Feb; 34(2):115-125. PubMed ID: 28118769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single rooms may help to prevent nosocomial bloodstream infection and cross-transmission of methicillin-resistant Staphylococcus aureus in intensive care units.
    Bracco D; Dubois MJ; Bouali R; Eggimann P
    Intensive Care Med; 2007 May; 33(5):836-840. PubMed ID: 17347828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost savings of universal decolonization to prevent intensive care unit infection: implications of the REDUCE MRSA trial.
    Huang SS; Septimus E; Avery TR; Lee GM; Hickok J; Weinstein RA; Moody J; Hayden MK; Perlin JB; Platt R; Ray GT
    Infect Control Hosp Epidemiol; 2014 Oct; 35 Suppl 3(Suppl 3):S23-31. PubMed ID: 25222894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-Based and Value-Based Decision Making About Healthcare Design: An Economic Evaluation of the Safety and Quality Outcomes.
    Zadeh R; Sadatsafavi H; Xue R
    HERD; 2015; 8(4):58-76. PubMed ID: 26123968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased financial burdens and lengths of stay in patients with healthcare-associated infections due to multidrug-resistant bacteria in intensive care units: A propensity-matched case-control study.
    Su LH; Chen IL; Tang YF; Lee JS; Liu JW
    PLoS One; 2020; 15(5):e0233265. PubMed ID: 32421700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?
    Ben-David D; Novikov I; Mermel LA
    Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methicillin-resistant Staphylococcus aureus prevention strategies in the ICU: a clinical decision analysis*.
    Ziakas PD; Zacharioudakis IM; Zervou FN; Mylonakis E
    Crit Care Med; 2015 Feb; 43(2):382-93. PubMed ID: 25377019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hand hygiene noncompliance and the cost of hospital-acquired methicillin-resistant Staphylococcus aureus infection.
    Cummings KL; Anderson DJ; Kaye KS
    Infect Control Hosp Epidemiol; 2010 Apr; 31(4):357-64. PubMed ID: 20184440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of nosocomial infection on cost of illness and length of stay in intensive care units.
    Chen YY; Chou YC; Chou P
    Infect Control Hosp Epidemiol; 2005 Mar; 26(3):281-7. PubMed ID: 15796281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of targeted surveillance for control of methicillin-resistant Staphylococcus aureus in a community hospital system.
    West TE; Guerry C; Hiott M; Morrow N; Ward K; Salgado CD
    Infect Control Hosp Epidemiol; 2006 Mar; 27(3):233-8. PubMed ID: 16532409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To isolate or not to isolate? Analysis of data from the German Nosocomial Infection Surveillance System regarding the placement of patients with methicillin-resistant Staphylococcus aureus in private rooms in intensive care units.
    Gastmeier P; Schwab F; Geffers C; Rüden H
    Infect Control Hosp Epidemiol; 2004 Feb; 25(2):109-13. PubMed ID: 14994934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unit.
    Salgado CD; Sepkowitz KA; John JF; Cantey JR; Attaway HH; Freeman KD; Sharpe PA; Michels HT; Schmidt MG
    Infect Control Hosp Epidemiol; 2013 May; 34(5):479-86. PubMed ID: 23571364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact on morbidity and costs of methicillin-resistant Staphylococcus aureus nosocomial pneumonia in intensive care patients].
    Larue A; Loos-Ayav C; Jay N; Commun N; Rabaud C; Bollaert PE
    Presse Med; 2009 Jan; 38(1):25-33. PubMed ID: 18771897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methicillin-resistant Staphylococcus aureus nosocomial infections in ICU: risk factors, morbidity and cost].
    Lepelletier D; Ferréol S; Villers D; Richet H
    Pathol Biol (Paris); 2004 Oct; 52(8):474-9. PubMed ID: 15465267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The business case for building better neonatal intensive care units.
    Shepley MM; Smith JA; Sadler BL; White RD
    J Perinatol; 2014 Nov; 34(11):811-5. PubMed ID: 25359412
    [No Abstract]   [Full Text] [Related]  

  • 17. Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital.
    Clancy M; Graepler A; Wilson M; Douglas I; Johnson J; Price CS
    Infect Control Hosp Epidemiol; 2006 Oct; 27(10):1009-17. PubMed ID: 17006806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare utilization and costs associated with S. aureus and P. aeruginosa pneumonia in the intensive care unit: a retrospective observational cohort study in a US claims database.
    Kyaw MH; Kern DM; Zhou S; Tunceli O; Jafri HS; Falloon J
    BMC Health Serv Res; 2015 Jun; 15():241. PubMed ID: 26093384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of contemporary hospital infrastructure pertaining to infection prevention in Germany].
    Stiller A; Schröder C; Gropmann A; Schwab F; Behnke M; Geffers C; Holzhausen J; Sunder W; Gastmeier P
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Aug; 59(8):986-91. PubMed ID: 27376655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs.
    Geissler A; Gerbeaux P; Granier I; Blanc P; Facon K; Durand-Gasselin J
    Intensive Care Med; 2003 Jan; 29(1):49-54. PubMed ID: 12528022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.